Fig. 4
A dose-response sigmoid curve in a logarithmic concentration of human fibroblast cell line (HFb-4) 48 h post-treatment with (A) MOF, (B) SOR, and (C) SOR-MIL-53 nanocomposites.
Fig. 4 | Scientific Reports
A dose-response sigmoid curve in a logarithmic concentration of human fibroblast cell line (HFb-4) 48 h post-treatment with (A) MOF, (B) SOR, and (C) SOR-MIL-53 nanocomposites.
